Clinical Trial Update: Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY) [Phase 2]

View source ↗

Summary

Phase 2 MELODY trial evaluating pegylated liposomal doxorubicin versus active surveillance in adults with advanced soft tissue sarcoma who had disease control a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft-tissue Sarcoma

Drugs mentioned

• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Advanced Soft Tissue Sarcoma | Phase 2 | Status: RECRUITING